Benefits of polyphenols on gut microbiota and implications in human health

Journal of Nutritional Biochemistry

Volumn 24, Issue 8, 2013, Pages 1415-1422

  Cardona, Fernando ^a,b   Andrés Lacueva, Cristina ^c,d   Tulipani, Sara ^a   Tinahones, Francisco J ^a,b   Queipo Ortuño, María Isabel ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INGENIO CONSOLIDER Program   (Spain)

Author keywords

Cancer; Dietary polyphenols; Gut microbiota; Human health; Immunity; Polyphenol bioavailability

Indexed keywords

POLYPHENOL;

BACTERIAL MEMBRANE; BIOAVAILABILITY; BIOTRANSFORMATION; CHEMICAL INTERACTION; DIETARY INTAKE; HEALTH; HUMAN; IMMUNITY; INTESTINE FLORA; METABOLISM; NEOPLASM; REVIEW;

CANCER; DIETARY POLYPHENOLS; GUT MICROBIOTA; HUMAN HEALTH; IMMUNITY; POLYPHENOL BIOAVAILABILITY;

BIOLOGICAL AVAILABILITY; CLINICAL TRIALS AS TOPIC; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; NEOPLASMS; POLYPHENOLS;

EID: 84892399073     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.05.001     Document Type: Review

References (115)

1. Puupponen-Pimiä R., Aura A.M., Oksman-Caldentey K.M., Myllärinen P., Saarela M., Mattila-Sandholm T., et al. Development of functional ingredients for gut health. Trends Food Sci Tech 2002, 13:3-11.
2. Neveu V., Perez-Jiménez J., Vos F., Crespy V., du Chaffaut L., Mennen L., et al. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database 2010, 10.1093/database/bap024.
3. Bingham M. Gastrointestinal microbiology 2006, 155-168. Taylor & Francis Group, New York. A.C. Ouwehand, E.E. Vaughan (Eds.).
4. Andrés-Lacueva C.A., Medina-Remon A., Llorach R., Urpi-Sarda M., Khan N., Chiva-Blanch G., et al. Phenolic compounds: chemistry and occurrence in fruits and vegetables. Fruit and Vegetable Phytochemicals: Chemistry, Nutritional Value and Stability 2009, 53-88. Blackwel Publishing, Ames, IA. L.A. de la Rosa, E. Álvarez-Parrilla, G.A. González-Aguilar (Eds.).
5. Appeldoorn M.M., Vincken J.P., Gruppen H., Hollman P.C. Procyanidin dimers A1, A2, and B2 are absorbed without conjugation or methylation from the small intestine of rats. J Nutr 2009, 139(8):1469-1473.
6. Bosscher D., Breynaert A., Pieters L., Hermans N. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. J Physiol Pharmacol 2009, 60(6):5-11.
7. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81(1):230S-242S.
8. Rasmussen S.E., Frederiksen H., Struntze K.K., Poulsen L. Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol Nutr Food Res 2005, 49(2):159-174.
9. Walle T. Absorption and metabolism of flavonoids. Free Radic Biol Med 2004, 36(7):829-837.
10. Monagas M., Urpi-Sarda M., Sánchez-Patán F., Llorach R., Garrido I., Gómez-Cordovés C., et al. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct 2010, 1(3):233-253.
11. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
12. D'Archivio M., Filesi C., Di Benedetto R., Gargiulo R., Giovannini C., Masella R. Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita 2007, 43:348-361.
13. Jacobs D.M., Gaudier E., van Duynhoven J., Vaughan E.E. Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics. Curr Drug Metab 2009, 10(1):41-54.
14. Kroon A.P., Clifford N.M., Crozier A., et al. How should we assess the effects of exposure to dietary polyphenols in vitro?. Am J Clin Nutr 2004, 80:15-21.
15. Manach C., Donovan L.J. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Rad Res. 2004, 38:771-785.
16. Serrano J., Puupponen-Pimiä R., Dauer A., Aura A.M., Saura-Calixto F. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. Mol Nutr Food Res 2009, 53:S310-S329.
17. Appeldoorn M.M., Vincken J.P., Aura A.M., Hollman P.C., Gruppen H. Procyanidin dimers are metabolized by human microbiota with 2-(3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-gamma-valerolactone as the major metabolites. J Agric Food Chem 2009, 57(3):1084-1092.
18. Urpi-Sarda M., Garrido I., Monagas M., Gómez-Cordovés C., Medina-Remón A., Andres-Lacueva C., et al. Profile of plasma and urine metabolites after the intake of almond [Prunus dulcis (Mill.) D.A. Webb] polyphenols in humans. J Agri. Food Chem 2009, 57(21):10134-10142.
19. Stoupi S., Williamson G., Drynan J.W., Barron D., Clifford M.N. A comparison of the in vitro biotransformation of (-)-epicatechin and procyanidin B2 by human faecal microbiota. Mol Nutr Food Res 2010, 54(6):747-759.
20. Déprez S., Brezillon C., Rabot S., Philippe C., Mila I., Lapierre C., et al. Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J Nutr 2000, 130(11):2733-2738.
21. Boto-Ordóñez M., Urpi-Sarda M., María Monagas M., Tulipani S., Llorach R., Rabassa-Bonet M., et al. Phenolic acids from microbial metabolism of dietary flavan-3-ols. Phenolic Acids: Composition, Applications and Health Benefits 2011, 147-172. Nova Science Publishers (EEUU) Inc. S. Munné-Bosch (Ed.).
22. Saura-Calixto F., Serrano J., Goñi I. Intake and bioaccessibility of total polyphenols in a whole diet. Food Chem 2007, 101:492-501.
23. Espín J.C., González-Barrio R., Cerdá B., López-Bote C., Rey A.I., Tomás-Barberán F.A. Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J Agric Food Chem 2007, 55(25):10476-10485.
24. Larrosa M., García-Conesa M.T., Espín J.C., Tomás-Barberán F.A. Ellagitannins, ellagic acid and vascular health. Mol Aspects Med 2010, 31(6):513-539.
25. Rothwell J.A., Urpi-Sarda M., Boto-Ordoñez M., Knox C., Llorach R., Eisner R., et al. Phenol-Explorer 2.0: a major update of the Phenol-Explorer database integrating data on polyphenol metabolism and pharmacokinetics in humans and experimental animals. Database 2012, 10.1093/database/bas031.
26. Kutschera M., Engst W., Blaut M., Braune A. Isolation of catechin-converting human intestinal bacteria. J Appl Microbiol 2011, 111:165-175.
27. Cerda B., Tomas-Barberan F.A., Espin J.C. Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability. J Agric Food Chem 2005, 53(2):227-235.
28. Gross G., Jacobs D.M., Peters S., Possemiers S., van Duynhoven J., Vaughan E.E., et al. In vitro bioconversion of polyphenols from black tea and red wine/grape juice by human intestinal microbiota displays strong interindividual variability. J Agric Food Chem 2010, 58(18):10236-10246.
29. Lee H.C., Jenner A.M., Low C.S., Lee Y.K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol 2006, 157(9):876-884.
30. Tzounis X., Rodriguez-Mateos A., Vulevic J., Gibson G.R., Kwik-Uribe C., Spencer J.P. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr 2011, 93(1):62-72.
31. Queipo-Ortuño M.I., Boto-Ordóñez M., Murri M., Gomez-Zumaquero J.M., Clemente-Postigo M., Estruch R., et al. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr 2012, 95(6):1323-1334.
32. Selma M.V., Espin J.C., Tomas-Barberan F.A. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 2009, 57:6485-6501.
33. Rastmanesh R. High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. Chem Biol Interact 2011, 189(1-2):1-8.
34. Hervert-Hernandez D., Goñi I. Dietary polyphenols and human gut microbiota: a review. Food Rev Int 2011, 27:154-169.
35. Laparra J.M., Sanz Y. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res 2010, 61(3):219-225.
36. Mandalari G., Bisignano C., D'Arrigo M., Ginestra G., Arena A., Tomaino A., et al. Antimicrobial potential of polyphenols extracted from almond skins. Lett Appl Microbiol 2010, 51(1):83-89.
37. Mandalari G., Faulks R.M., Bisignano C., Waldron K.W., Narbad A., Wickham M.S. In vitro evaluation of the prebiotic properties of almond skins (Amygdalus communis L.). FEMS Microbiol Lett 2010, 304(2):116-122.
38. Oliveira I., Sousa A., Morais J.S., Ferreira I.C., Bento A., Estevinho L., et al. Chemical composition, and antioxidant and antimicrobial activities of three hazelnut (Corylus avellana L.) cultivars. Food Chem Toxicol 2008, 46(5):1801-1807.
39. Duggan C., Gannon J., Walker W.A. Protective nutrients and functional foods for the gastrointestinal tract. Am J Clin Nutr 2002, 75:789-808.
40. Gotteland M., Andrews M., Toledo M., Muñoz L., Caceres P., Anziani A., et al. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children. Nutr 2008, 24(5):421-426.
41. Vitali B., Ndagijimana M., Cruciani F., Carnevali P., Candela M., Guerzoni M.E., et al. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 2010, 10:4.
42. Jennings A., Welch A.A., Fairweather-Tait S.J., Kay C., Minihane A.M., Chowienczyk P., et al. Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am J Clin Nutr 2012, 96(4):781-788.
43. Cassidy A., O'Reilly É.J., Kay C., Sampson L., Franz M., Forman J.P., et al. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr 2011, 93(2):338-347.
44. Hooper L., Kay C., Abdelhamid A., Kroon P.A., Cohn J.S., Rimm E.B., et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr 2012, 95(3):740-751.
45. Chiva-Blanch G., Urpi-Sarda M., Ros E., Valderas-Martinez P., Casas R., Arranz S., et al. Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: a randomized clinical trial. Clin Nutr 2012, [Epub ahead of print]. 10.1016/j.clnu.2012.08.022.
46. Chiva-Blanch G., Urpi-Sarda M., Ros E., Arranz S., Valderas-Martinez P., Casas R., et al. Dealcoholized red wine decreases systolic and diastolic blood pressure and increases plasma nitric oxide: short communication. Circ Res 2012, 111(8):1065-1068.
47. Zamora-Ros R., Agudo A., Luján-Barroso L., Romieu I., Ferrari P., Knaze V., et al. Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr 2012, 96(6):1398-1408.
48. Hanhineva K., Törrönen R., Bondia-Pons I., Pekkinen J., Kolehmainen M., Mykkänen H., et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010, 11(4):1365-1402.
49. Bowey E., Adlercreutz H., Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol 2003, 41:631-636.
50. Aura A.M., Martin-Lopez P., O'Leary K.A., Williamson G., Oksman-Caldentey K.M., Poutanen K., et al. In vitro metabolism of anthocyanins by human gut microflora. Eur J Nutr 2005, 44:133-142.
51. Santos-Buelga C., Scalbert A. Proanthocyanidins and tannin-like compounds: nature, occurrence, dietary intake and effects on nutrition and health. J Sci Food Agric 2000, 80:1094-1117.
52. Mahowald M.A., Rey F.E., Seedorf H., Turnbaugh P.J., Fulton R.S., Wollam A., et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci USA 2009, 106:5859-5864.
53. Gonthier M.P., Cheynier V., Donovan J.L., Manach C., Morand C., Mila I., et al. Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J Nutr 2003, 133(2):461-467.
54. Forester S.C., Waterhouse A. Identification of Cabernet Sauvignon anthocyanin gut microflora metabolites. J Agric Food Chem 2008, 56(19):9299-92304.
55. Lala G., Malik M., Zhao C., He J., Kwon Y., Giusti M.M., et al. Anothocanin-rich extracts inhibits multiple biomarkers of colon cancer in rats. Nutr. 2006, 54:84-93.
56. Bolca S., Urpi-Sarda M., Blondeel P., Roche N., Vanhaecke L., Possemiers S., et al. Disposition of soy isoflavones in normal human breast tissue. Am J Clin Nutr 2010, 91(4):976-984.
57. van Dorsten F.A., Grün C.H., van Velzen E.J., Jacobs D.M., Draijer R., van Duynhoven J.P. The metabolic fate of red wine and grape juice polyphenols in humans assessed by metabolomics. Mol Nutr Food Res 2010, 54(7):897-908.
58. Hervert-Hernandez D., Pintado C., Rotger R., Goni I. Stimulatory role of grape pomace polyphenols on Lactobacillus acidophilus growth. Int J Food Microbiol 2009, 136:119-122.
59. Tzonuis X., Vulevic J., Kuhnle G.G., George T., Leonczak J., Gibson G.R., et al. Flavanol monomer-induced changes to the human faecal microflora. Br J Nutr 2008, 99:782-792.
60. Dolara P., Luceri C., De Filippo C., Femia A.P., Giovannelli L., Caderni G., et al. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats. Mutat Res 2005, 591:237-246.
61. Yamakoshi J., Tokutake S., Kikuchi M. Effect of proanthocyanidin- rich extract from grape seeds on human fecal flora andfecal odor. Microb Ecol Health Dis 2001, 13:25-31.
62. Molan A.L., Liu Z., Kruger M. The ability of blackcurrant extracts to positively modulate key markers of gastrointestinal function in rats. World J Microbiol Biotechnol 2011, 26:1735-1743.
63. Viveros A., Chamorro S., Pizarro M., Arija I., Centeno C., Brenes A. Effects of dietary polyphenol-rich grape products on intestinal microflora and gut morphology in broiler chicks. Poult Sci 2011, 90:566-578.
64. Massot-Cladera M., Pérez-Berezo T., Franch A., Castell M., Pérez-Cano F.J. Cocoa modulatory effect on rat faecal microbiota and colonic crosstalk. Arch Biochem Biophys 2012, 527(2):105-112.
65. Smith A.H., Zoetendal E., Mackie R.I. Bacterial mechanisms to overcome inhibitory effects of dietary tannins. Microb Ecol 2005, 50:197-205.
66. Larrosa M., Yáñez-Gascón M.J., Selma M.A., González-Sarrías A., Toti S., Cerón J.J., et al. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. J Agric Food Chem 2009, 57:2211-2220.
67. Vendrame S., Guglielmetti S., Riso P., Arioli S., Klimis-Zacas D., Porrini M. Six-week consumption of a wild blueberry powder drink increases bifidobacteria in the human gut. J Agric Food Chem 2011, 59(24):12815-12820.
68. Cueva C., Sánchez-Patán F., Monagas M., Walton G.E., Gibson G.R., Martín-Álvarez P.J., et al. In vitro fermentation of grape seed flavan-3-ol fractions by human faecal microbiota: changes in microbial groups and phenolic metabolites. FEMS Microbiol Ecol 2012, 10.1111/1574-6941.12037.
69. Puupponen-Pimiä R., Nohynek L., Hartman-Schmidlin S., Kähkönen M., Heinonen M., Mata-Riihinen K., et al. Berry phenolics selectively inhibit the growth of intestinal pathogens. J Appl Microbiol 2005, 98:991-1000.
70. Kemperman R.A., Bolca S., Roger L.C., Vaughan E.E. Novel approaches for analysing gut microbes and dietary polyphenols: challenges and opportunities. Microbiology 2010, 156(11):3224-3231.
71. Haslam E., Lilley T.H., Warminski E., Liao H., Cai Y., Martin R., et al. Polyphenol complexation. A study in molecular recognition. ACS Symp Ser. 1992, 506:8-50.
72. Hattori M., Kusumoto I.T., Namba T., Ishigami T., Hara Y. Effect of tea polyphenols on glucan synthesis by glucosyltransferase from Streptococcus mutans. Chem Pharm Bull 1990, 38:717-720.
73. Sirk T.W., Friedman M., Brown E.F. Molecular binding of black tea theaflavins to biological membranes: relationship to bioactivities. J Agric Food Chem 2011, 59(8):3780-7787.
74. Sirk T.W., Brown E.F., Friedman M., Sum A.K. Molecular binding of catechins to biomembranes: relationship to biological activity. J Agric Food Chem 2009, 57(15):6720-6728.
75. Stapleton P.D., Shah S., Ehlert K., Hara Y., Taylor P.W. The beta-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus. Microbiology 2007, 153(7):2093-2103.
76. Hu L., Wang H., Pei J., Liu Y. Research progress of antitumor effects of resveratrol and its mechanism. Shandong Yiyao 2010, 50:111-112.
77. González J.E., Keshavan N.D. Messing with bacterial quorum sensing. Microbiol Mol Biol Rev 2006, 70(4):859-875.
78. Williams P. Quorum sensing, communication and cross-kingdom signalling in the bacterialwWorld. Microbiology 2007, 153:3923-3938.
79. Hubert B., Eberl L., Feucht W., Polster J. Influence of polyphenols on bacterial biofilm formation and quorum-sensing. Z Naturforsch 2003, 58:879-884.
80. Tombola F., Campello S., De Luca L., Ruggiero P., Del Giudice G., Papini E., et al. Plant polyphenols inhibit VacA, a toxin secreted by the gastric pathogen Helicobacter pylori. FEBS Lett 2003, 543:184-189.
81. Lin Y.T., Vattem D.A., Labbe R.G., Shetty K. Inhibition of Helicobacter pylori by phenolic phytochemical enriched alcoholic beverages. Process Biochem 2005, 40(6):2059-2065.
82. Cushnie T.P., Lamb A.J. Antimicrobial activity of flavonoids. Int J Antimicrob Agents 2005, 26(5):343-356.
83. Plaper A., Golob M., Hafner I., Oblak M., Solmajer T., Jerala R. Characterization of quercetin binding site on DNA gyrase. Biochem Biophys Res Commun 2003, 306(2):530-536.
84. Gradišar H., Pristovsek P., Plaper A., Jerala R. Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. J Med Chem 2007, 50(2):264-271.
85. Park K.M., You J.S., Lee H.Y., Baek N.I., Hwang J.K. Kuwanon G: an antibacterial agent from the root bark of Morus alba against oral pathogens. J Ethnopharmacol 2003, 84:181-185.
86. Percival R.S., Devine D.A., Duggal M.S., Chartron S., Marsh P.D. The effect of cocoa polyphenols on the growth, metabolism, and biofilm formation by Streptococcus mutans and Streptococcus sanguinis. Eur J Oral Sci 2006, 114:343-348.
87. Prabu G.R., Gnanamani A., Sadulla S. Guaijaverin-a plant flavonoid as potential antiplaque agent against Streptococcus mutans. J Appl Microbiol 2006, 101:487-495.
88. Freestone P.E.F., Walton N.J., Haigh R., Lyte M. Influence of dietary catechols on the growth of enteropathogenic bacteria. Int J Food Microbiol 2007, 119:159-169.
89. Duttona R.J., Turnbaugh P.J. Taking a metagenomic view of human nutrition. Curr Opin Clin Nutr Metab Care 2012, 15:448-454.
90. Macdonald R.S., Wagner K. Influence of dietary phytochemicals and microbiota on colon cancer. J Agric Food Chem 2012, 60:6728-6735.
91. Woting A., Clavel T., Loh G., Blaut M. Bacterial transformation of dietary lignans in gnotobiotic rats. FEMS Microbiol Ecol 2010, 72:507-514.
92. Blaut M., Clavel T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 2007, 137:751S-755S.
93. Mabrok H.B., Klopfleisch R., Ghanem K.Z., Clavel T., Blaut M., Loh G. Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis 2012, 33:203-208.
94. Sengottuvelan M., Nalini N. Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development. Br J Nutr 2006, 96(1):145-153.
95. Namasivayam N. Chemoprevention in experimental animals. Ann N Y Acad Sci 2011, 1215:60-71.
96. Miene C., Weise A., Glei M. Impact of polyphenol metabolites produced by colonic microbiota on expression of COX-2 and GSTT2 in human colon cells (LT97). Nutr Cancer 2011, 63(4):653-662.
97. Losso J.N., Bansode R.R., Trappey A., Bawadi H.A., Truax R. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 2004, 15(11):672-678.
98. Tulipani S., Urpi-Sarda M., García-Villalba R., Rabassa M., López-Uriarte P., Bullo M., et al. Urolithins are the main urinary microbial-derived phenolic metabolites discriminating a moderate consumption of nuts in free-living subjects with diagnosed metabolic syndrome. J Agric Food Chem 2012, 60(36):8930-8940.
99. Larrosa M., González-Sarrías A., García-Conesa M.T., Tomás-Barberán F.A., Espín J.C. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 2006, 54(5):1611-1620.
100. Kang N.J., Lee K.W., Kim B.H., Bode A.M., Lee H.J., Heo Y.S., et al. Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. Carcinogenesis 2011, 32:921-928.
101. Butt M.S., Sultan M.T. Green tea: nature's defense against malignancies. Crit Rev Food Sci Nutr 2009, 49:463-473.
102. Singh B.N., Shankar S., Srivastava R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 2011, 82(12):1807-1821.
103. Gibellini L., Pinti M., Nasi M., Montagna J.P., De Biasi S., Roat E., et al. Quercetin and cancer chemoprevention. Evidence-Based Complement Alternat Med 2011, 10.1093/ecam/meq053.
104. Fogliano V., Corollaro M.L., Vitaglione P., Napolitano A., Ferracane R., Travaglia F., et al. In vitro bioaccessibility and gut biotransformation of polyphenols present in the water-insoluble cocoa fraction. Mol Nutr Food Res 2011, 55(1):44-55.
105. Self W.T. Regulation of purine hydroxylase and xanthine dehydrogenase from Clostridium purinolyticum in response to purines, selenium, and molybdenum. J Bacteriol 2002, 184(7):2039-2044.
106. Hage F.G., Szalai A.J. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol 2007, 50(12):1115-1122.
107. Ridker P.M., Cook N.R. Biomarkers for prediction of cardiovascular events. N Engl J Med 2007, 356(14):1472-1473.
108. Martin F.P., Rezzi S., Peré-Trepat E., Kamlage B., Collino S., Leibold E., et al. Metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress-related metabolism in free-living subjects. J Proteome Res 2009, 8(12):5568-5579.
109. Monagas M., Khan N., Andreś-Lacueva C., Urpi-́Sarda M., Vazquez-Agell M., Lamuela-Raventós R.M., et al. Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells. Br J Nutr 2009, 102:201-206.
110. Tuohy K.M., Conterno L., Gasperotti M., Viola R. Up-regulating the human intestinal microbiome using whole plant foods, polyphenols, and/or fiber. J Agric Food Chem 2012, 60(36):8776-8782.
111. Larrosa M., Luceri C., Vivoli E., Pagliuca C., Lodovici M., Moneti G., et al. Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. Mol Nutr Food Res 2009, 53:1044-1054.
112. Verzelloni E., Pellacani C., Tagliazucchi D., Tagliaferri S., Calani L., Costa L.G., et al. Antiglycative and neuroprotective activity of colon derived polyphenol catabolites. Mol Nutr Food Res 2011, 55(1):S35-S43.
113. Tucsek Z., Radnai B., Racz B., Debreceni B., Priber J.K., Dolowschiak T., et al. Suppressing LPS-induced early signal transduction in macrophages by a polyphenol degradation product: a critical role of MKP-1. J Leukoc Biol 2011, 89:105-111.
114. Chirumbolo S. The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm Allergy Drug Targets 2010, 9:263-285.
115. Beloborodova N., Bairamov I., Olenin A., Shubina V., Teplova V., Fedotcheva N. Effect of phenolic acids of microbial origin on production of reactive oxygen species in mitochondria and neutrophils. J Biomed Sci 2012, 19:89.